Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.
about
Tumor Heterogeneity, Single-Cell Sequencing, and Drug ResistanceNext-generation sequencing: advances and applications in cancer diagnosisDe novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers.Changing paradigm of cancer therapy: precision medicine by next-generation sequencing.Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.Kinase inhibitor-responsive genotypes in EGFR mutated lung adenocarcinomas: moving past common point mutations or indels into uncommon kinase domain duplications and rearrangements.Digenic heterozygous mutations in EYS/LRP5 in a Chinese family with retinitis pigmentosa.Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture.NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?Tumor biomarker testing in non-small-cell lung cancer: A decade of change.Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model.
P2860
Q26744341-43262A21-BFF4-4329-9EC3-1267E0C3B59FQ28073891-F7818140-5DB5-4929-82C8-C814289B2BA3Q36114660-03BDEA90-328C-482C-895F-2122EEBEAA27Q36849642-88DE5477-5FEE-49CE-9C19-023F42862079Q36927538-6DE254EC-15A8-4F02-B2D4-3AE90C43E5BBQ37060709-3E140A5D-A19B-40CE-8ADA-1BF8699BB218Q37647864-865E24F4-E3A6-42B9-92AD-7ADD5264C582Q37716406-FD5C88F3-8773-4483-A189-6497D8124B95Q42695934-3B0CA912-C33E-450D-8772-69D0590890C7Q50139910-D8A679B7-06F4-4FD0-87D3-9BCC2C70A456Q51037196-66EA31DE-62EE-49A4-8015-69C197962F0DQ52633438-A9477ABC-0516-4522-AE35-8E9A778D1DEA
P2860
Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Experience with targeted next ...... cology in day-to-day practice.
@ast
Experience with targeted next ...... cology in day-to-day practice.
@en
type
label
Experience with targeted next ...... cology in day-to-day practice.
@ast
Experience with targeted next ...... cology in day-to-day practice.
@en
prefLabel
Experience with targeted next ...... cology in day-to-day practice.
@ast
Experience with targeted next ...... cology in day-to-day practice.
@en
P2093
P2860
P50
P1476
Experience with targeted next ...... cology in day-to-day practice.
@en
P2093
Adnan Majid
Deepa Rangachari
Erik Folch
Loren J Joseph
Mark S Huberman
Michael S Kent
Richard L Haspel
Xiuning Le
P2860
P304
P356
10.1016/J.CTRC.2015.10.004
P577
2015-01-01T00:00:00Z